Method for novel anti-cancer drug development using tumor explants of surgical specimens. (Q38764442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Method for novel anti-cancer drug development using tumor explants of surgical specimens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Kaushal Joshi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Habibe Demir

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ryosuke Yamada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Abhik Ray-Chaudhury

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ichiro Nakano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

29 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

Journal of Visualized Experiments

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

Glycoproteomic analysis of glioblastoma stem cell differentiation

10 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Neurosphere formation is an independent predictor of clinical outcome in malignant glioma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Cancerous stem cells can arise from pediatric brain tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3197442

[Expression of stem cell markers and proliferative labeling on glioma cell lines]

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21841761

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3791/2846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21841761%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

21841761

1 reference